Merck & Co., Inc. HIV Drug from Schering-Plough Corporation Merger Fails Trials

Bookmark and Share

Reuters -- Merck & Co on Wednesday said its experimental HIV treatment vicriviroc proved ineffective in two late-stage studies involving patients who had previously been treated with other HIV medicines.

Back to news